• Home
  • Textbooks
  • Pharmacology
  • Antifungal Drugs

Pharmacology

George M. Brenner, Craig W. Stevens

Chapter 42

Antifungal Drugs - all with Video Answers

Educators


Chapter Questions

01:35

Problem 1

After completing amphotericin B treatment for a cryptococcal infection, a man with HIV infection is placed on a drug to prevent relapse of his fungal infection. Which pharmacologic property is associated with this drug?
(A) poor oral bioavailability
(B) low cerebrospinal fluid concentrations
(C) primarily excreted in the bile
(D) long elimination half-life
(E) must be given parenterally

Dennis Howard
Dennis Howard
Numerade Educator
00:39

Problem 2

A woman is given a drug that inhibits fungal cell wall synthesis. Which infection is most likely being treated in this patient?
(A) tinea corporis
(B) esophageal candidiasis
(C) cryptococcal meningitis
(D) blastomycosis
(E) mucormycosis

Tate Hilken
Tate Hilken
Numerade Educator
01:33

Problem 3

After beginning oral therapy for onychomycosis, a woman develops a mild skin rash. This medication causes accumulation of which metabolite in fungal cells?
(A) lanosterol
(B) ergosterol
(C) cholesterol
(D) cytosine
(E) $\beta$-(1,3)-d-glucan

Dennis Howard
Dennis Howard
Numerade Educator
01:24

Problem 4

A child with tinea capitis is treated with an agent that inhibits microtubule function in fungi. Which adverse effect most commonly results from this treatment?
(A) diarrhea
(B) constipation
(C) nausea
(D) blurred vision
(E) insomnia

Brett Donadeo
Brett Donadeo
Numerade Educator